Intarcia Therapeutics
ClosedUnlocking life's possibilities
San Francisco, United States · Founded 1997 · $210.0M raised
- Headquarters
- San Francisco
- Employees
- 201–500
- Founded
- 1997
- Business Model
- Other
- Website
- intarcia.com
- Total Funding
- $210.0M
- Last Round
- $210.0M Venture RoundNov 2012
- Rounds
- 1
About
Intarcia Therapeutics, Inc. is a rapidly emerging biotech company committed to redesigning the treatment, prevention, and experience of chronic disease. The company operates with a 'No Analog' mindset, pushing boundaries with cross-disciplinary teams of scientists and entrepreneurs. Founded in 1997, it previously focused on implantable drug delivery devices and has raised significant funding.
Summary
Intarcia Therapeutics is a Pharmaceutical company based in San Francisco, United States, founded in 1997. It has raised $210.0M in total across 1 round, most recently a $210.0M Venture Round round in Nov 2012.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2012
Similar Companies
Biotech developing in vivo CAR-T cell therapies. Acquired by AbbVie for $2.1B upfront in 2024.
Biotech developing EPiC peptide compounds to cross the blood-brain barrier for treating brain dis...
Ankyra is developing cancer therapies based on localized cytokines that prime a systemic adaptive...
Painless, convenient transdermal patient administration of therapeutic proteins and vaccines
Escient is a clinical-stage pharmaceutical company focused on discovering and developing first-in...
AI-powered drug discovery platform